---
layout: default
title: Developing Large Language Models for Clinical Research Using One Million Clinical Trials
---

# Developing Large Language Models for Clinical Research Using One Million Clinical Trials

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2505.16097" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2505.16097</a>
  <a href="https://arxiv.org/pdf/2505.16097.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2505.16097" onclick="toggleFavorite(this, '2505.16097', 'Developing Large Language Models for Clinical Research Using One Million Clinical Trials')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Zifeng Wang, Jiacheng Lin, Qiao Jin, Junyi Gao, Jathurshan Pradeepkumar, Pengcheng Jiang, Zhiyong Lu, Jimeng Sun

**åˆ†ç±»**: cs.AI

**å‘å¸ƒæ—¥æœŸ**: 2025-12-18

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**TrialPanoramaï¼šæ„å»ºç™¾ä¸‡çº§ä¸´åºŠè¯•éªŒæ•°æ®é›†ï¼Œæå‡LLMåœ¨ä¸´åºŠç ”ç©¶ä»»åŠ¡ä¸­çš„æ€§èƒ½**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±äºŒï¼šRLç®—æ³•ä¸æ¶æ„ (RL & Architecture)** **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `ä¸´åºŠç ”ç©¶` `å¤§å‹è¯­è¨€æ¨¡å‹` `æ•°æ®é›†æ„å»º` `ç›‘ç£å¾®è°ƒ` `å¼ºåŒ–å­¦ä¹ ` `ä¸´åºŠè¯•éªŒ` `è‡ªç„¶è¯­è¨€å¤„ç†`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰é€šç”¨LLMåœ¨ä¸´åºŠæ¨ç†æ–¹é¢èƒ½åŠ›æœ‰é™ï¼Œéš¾ä»¥æ»¡è¶³ä¸´åºŠç ”ç©¶çš„ç‰¹å®šéœ€æ±‚ã€‚
2. è®ºæ–‡æ„å»ºTrialPanoramaæ•°æ®é›†ï¼Œå¹¶åœ¨æ­¤åŸºç¡€ä¸Šå¾®è°ƒLLMï¼Œä»¥æå‡å…¶åœ¨ä¸´åºŠç ”ç©¶ä»»åŠ¡ä¸­çš„æ€§èƒ½ã€‚
3. å®éªŒç»“æœè¡¨æ˜ï¼ŒåŸºäºTrialPanoramaè®­ç»ƒçš„8B LLMåœ¨å¤šä¸ªä¸´åºŠç ”ç©¶ä»»åŠ¡ä¸Šæ˜¾è‘—ä¼˜äºé€šç”¨LLMã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

æœ¬æ–‡ä»‹ç»äº†ä¸€ä¸ªåä¸ºTrialPanoramaçš„å¤§è§„æ¨¡ç»“æ„åŒ–èµ„æºï¼Œå®ƒæ±‡é›†äº†æ¥è‡ª15ä¸ªå…¨çƒæ³¨å†Œæœºæ„çš„160ä¸‡æ¡ä¸´åºŠè¯•éªŒè®°å½•ï¼Œå¹¶å°†å®ƒä»¬ä¸ç”Ÿç‰©åŒ»å­¦æœ¬ä½“å’Œç›¸å…³æ–‡çŒ®è”ç³»èµ·æ¥ã€‚ä¸ºäº†å±•ç¤ºå…¶æ•ˆç”¨ï¼Œä½œè€…æ„å»ºäº†ä¸€ä¸ªpipelineï¼Œä¸ºå…«ä¸ªå…³é”®ä¸´åºŠç ”ç©¶ä»»åŠ¡æ„å»ºäº†15.2ä¸‡ä¸ªè®­ç»ƒå’Œæµ‹è¯•æ ·æœ¬ã€‚è¿™äº›ä»»åŠ¡åŒ…æ‹¬æ”¯æŒç³»ç»Ÿè¯„ä»·å·¥ä½œæµç¨‹ï¼ˆç ”ç©¶æœç´¢ã€ç ”ç©¶ç­›é€‰å’Œè¯æ®æ€»ç»“ï¼‰ä»¥åŠå…³æ³¨è¯•éªŒè®¾è®¡å’Œä¼˜åŒ–ï¼ˆè‡‚è®¾è®¡ã€çº³å…¥æ ‡å‡†è®¾è®¡ã€ç»ˆç‚¹é€‰æ‹©ã€æ ·æœ¬é‡ä¼°è®¡ä»¥åŠè¯•éªŒå®Œæˆè¯„ä¼°å’Œåˆç†åŒ–ï¼‰ã€‚å¯¹å…ˆè¿›å¤§å‹è¯­è¨€æ¨¡å‹ï¼ˆLLMï¼‰çš„åŸºå‡†æµ‹è¯•è¡¨æ˜ï¼Œé€šç”¨LLMåœ¨ä¸´åºŠæ¨ç†æ–¹é¢çš„èƒ½åŠ›æœ‰é™ã€‚ç›¸æ¯”ä¹‹ä¸‹ï¼Œä½œè€…åœ¨TrialPanoramaä¸Šä½¿ç”¨ç›‘ç£å¾®è°ƒå’Œå¼ºåŒ–å­¦ä¹ å¼€å‘çš„8B LLMåœ¨æ‰€æœ‰å…«ä¸ªä»»åŠ¡ä¸­éƒ½ä¼˜äº70Bçš„é€šç”¨LLMï¼Œç›¸å¯¹æ”¹è¿›åˆ†åˆ«ä¸º73.7%ã€67.6%ã€38.4%ã€37.8%ã€26.5%ã€20.7%ã€20.0%ã€18.1%å’Œ5.2%ã€‚TrialPanoramaä¸ºæœªæ¥æ‰©å±•ä¸´åºŠç ”ç©¶AIæä¾›äº†åšå®çš„åŸºç¡€ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šç°æœ‰çš„å¤§å‹è¯­è¨€æ¨¡å‹åœ¨å¤„ç†ä¸´åºŠç ”ç©¶ä»»åŠ¡æ—¶ï¼Œç”±äºç¼ºä¹é’ˆå¯¹æ€§çš„è®­ç»ƒæ•°æ®å’Œé¢†åŸŸçŸ¥è¯†ï¼Œè¡¨ç°å‡ºä¸´åºŠæ¨ç†èƒ½åŠ›ä¸è¶³çš„é—®é¢˜ã€‚è¿™é™åˆ¶äº†å®ƒä»¬åœ¨ä¸´åºŠç ”ç©¶ä¸­çš„åº”ç”¨ï¼Œä¾‹å¦‚ç³»ç»Ÿè¯„ä»·ã€è¯•éªŒè®¾è®¡å’Œä¼˜åŒ–ç­‰ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šè®ºæ–‡çš„æ ¸å¿ƒæ€è·¯æ˜¯æ„å»ºä¸€ä¸ªå¤§è§„æ¨¡çš„ã€ç»“æ„åŒ–çš„ä¸´åºŠè¯•éªŒæ•°æ®é›†TrialPanoramaï¼Œå¹¶åˆ©ç”¨è¯¥æ•°æ®é›†å¯¹LLMè¿›è¡Œå¾®è°ƒï¼Œä½¿å…¶èƒ½å¤Ÿæ›´å¥½åœ°ç†è§£å’Œå¤„ç†ä¸´åºŠç ”ç©¶ç›¸å…³çš„ä»»åŠ¡ã€‚é€šè¿‡ç›‘ç£å¾®è°ƒå’Œå¼ºåŒ–å­¦ä¹ ï¼Œä½¿æ¨¡å‹å­¦ä¹ åˆ°ç‰¹å®šé¢†åŸŸçš„çŸ¥è¯†å’Œæ¨ç†èƒ½åŠ›ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šè¯¥ç ”ç©¶çš„æŠ€æœ¯æ¡†æ¶ä¸»è¦åŒ…æ‹¬ä»¥ä¸‹å‡ ä¸ªæ­¥éª¤ï¼š1) æ•°æ®æ”¶é›†ä¸æ•´åˆï¼šä»15ä¸ªå…¨çƒä¸´åºŠè¯•éªŒæ³¨å†Œæœºæ„æ”¶é›†æ•°æ®ï¼Œå¹¶è¿›è¡Œæ¸…æ´—å’Œæ•´åˆã€‚2) æ•°æ®ç»“æ„åŒ–ï¼šå°†ä¸´åºŠè¯•éªŒæ•°æ®ä¸ç”Ÿç‰©åŒ»å­¦æœ¬ä½“å’Œç›¸å…³æ–‡çŒ®è¿›è¡Œé“¾æ¥ï¼Œæ„å»ºç»“æ„åŒ–çš„TrialPanoramaæ•°æ®é›†ã€‚3) ä»»åŠ¡æ„å»ºï¼šåŸºäºTrialPanoramaæ•°æ®é›†ï¼Œæ„å»ºå…«ä¸ªå…³é”®ä¸´åºŠç ”ç©¶ä»»åŠ¡çš„è®­ç»ƒå’Œæµ‹è¯•æ ·æœ¬ã€‚4) æ¨¡å‹è®­ç»ƒä¸è¯„ä¼°ï¼šä½¿ç”¨ç›‘ç£å¾®è°ƒå’Œå¼ºåŒ–å­¦ä¹ åœ¨TrialPanoramaæ•°æ®é›†ä¸Šè®­ç»ƒLLMï¼Œå¹¶åœ¨å…«ä¸ªä»»åŠ¡ä¸Šè¿›è¡Œè¯„ä¼°ã€‚

**å…³é”®åˆ›æ–°**ï¼šè¯¥ç ”ç©¶çš„å…³é”®åˆ›æ–°åœ¨äºæ„å»ºäº†TrialPanoramaæ•°æ®é›†ï¼Œè¿™æ˜¯ä¸€ä¸ªå¤§è§„æ¨¡çš„ã€ç»“æ„åŒ–çš„ä¸´åºŠè¯•éªŒèµ„æºï¼Œä¸ºLLMåœ¨ä¸´åºŠç ”ç©¶é¢†åŸŸçš„åº”ç”¨æä¾›äº†æ•°æ®åŸºç¡€ã€‚æ­¤å¤–ï¼Œé€šè¿‡ç›‘ç£å¾®è°ƒå’Œå¼ºåŒ–å­¦ä¹ ï¼Œæœ‰æ•ˆåœ°æå‡äº†LLMåœ¨ä¸´åºŠç ”ç©¶ä»»åŠ¡ä¸­çš„æ€§èƒ½ã€‚

**å…³é”®è®¾è®¡**ï¼šè®ºæ–‡ä¸­ä½¿ç”¨äº†ç›‘ç£å¾®è°ƒå’Œå¼ºåŒ–å­¦ä¹ ä¸¤ç§æ–¹æ³•æ¥è®­ç»ƒLLMã€‚ç›‘ç£å¾®è°ƒä½¿ç”¨æ ‡æ³¨å¥½çš„è®­ç»ƒæ•°æ®æ¥è°ƒæ•´æ¨¡å‹çš„å‚æ•°ï¼Œä½¿å…¶æ›´å¥½åœ°é€‚åº”ç‰¹å®šä»»åŠ¡ã€‚å¼ºåŒ–å­¦ä¹ åˆ™é€šè¿‡å¥–åŠ±æœºåˆ¶æ¥å¼•å¯¼æ¨¡å‹å­¦ä¹ ï¼Œä½¿å…¶èƒ½å¤Ÿæ›´å¥½åœ°å®Œæˆä»»åŠ¡ã€‚å…·ä½“å‚æ•°è®¾ç½®å’ŒæŸå¤±å‡½æ•°ç­‰æŠ€æœ¯ç»†èŠ‚åœ¨è®ºæ–‡ä¸­æœªè¯¦ç»†è¯´æ˜ï¼Œå±äºæœªçŸ¥ä¿¡æ¯ã€‚

## ğŸ–¼ï¸ å…³é”®å›¾ç‰‡

<div class="paper-figures">
<figure class="paper-figure">
<img src="https://arxiv.org/html/2505.16097/x1.png" alt="fig_0" loading="lazy">
</figure>
<figure class="paper-figure">
<img src="https://arxiv.org/html/2505.16097/x2.png" alt="fig_1" loading="lazy">
</figure>
<figure class="paper-figure">
<img src="https://arxiv.org/html/2505.16097/x3.png" alt="fig_2" loading="lazy">
</figure>
</div>

## ğŸ“Š å®éªŒäº®ç‚¹

å®éªŒç»“æœè¡¨æ˜ï¼ŒåŸºäºTrialPanoramaæ•°æ®é›†è®­ç»ƒçš„8B LLMåœ¨å…«ä¸ªå…³é”®ä¸´åºŠç ”ç©¶ä»»åŠ¡ä¸­å‡ä¼˜äº70Bçš„é€šç”¨LLMã€‚å…·ä½“è€Œè¨€ï¼Œç›¸å¯¹æ”¹è¿›å¹…åº¦åˆ†åˆ«ä¸º73.7%ã€67.6%ã€38.4%ã€37.8%ã€26.5%ã€20.7%ã€20.0%ã€18.1%å’Œ5.2%ã€‚è¿™äº›ç»“æœè¡¨æ˜ï¼Œé’ˆå¯¹ç‰¹å®šé¢†åŸŸçš„æ•°æ®é›†å’Œè®­ç»ƒæ–¹æ³•èƒ½å¤Ÿæ˜¾è‘—æå‡LLMåœ¨è¯¥é¢†åŸŸçš„æ€§èƒ½ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶æˆæœå¯åº”ç”¨äºä¸´åºŠç ”ç©¶çš„å¤šä¸ªé¢†åŸŸï¼Œä¾‹å¦‚åŠ é€Ÿç³»ç»Ÿè¯„ä»·æµç¨‹ã€ä¼˜åŒ–ä¸´åºŠè¯•éªŒè®¾è®¡ã€è¾…åŠ©åŒ»ç”Ÿè¿›è¡Œå†³ç­–ç­‰ã€‚TrialPanoramaæ•°æ®é›†å’Œè®­ç»ƒå¥½çš„LLMå¯ä»¥ä½œä¸ºä¸´åºŠç ”ç©¶äººå‘˜çš„æœ‰åŠ›å·¥å…·ï¼Œæé«˜ç ”ç©¶æ•ˆç‡å’Œè´¨é‡ï¼Œå¹¶æœ€ç»ˆæ”¹å–„æ‚£è€…çš„æ²»ç–—æ•ˆæœã€‚æœªæ¥ï¼Œè¯¥æ–¹æ³•æœ‰æœ›æ‰©å±•åˆ°å…¶ä»–åŒ»å­¦é¢†åŸŸï¼Œæ¨åŠ¨AIåœ¨åŒ»ç–—å¥åº·é¢†åŸŸçš„åº”ç”¨ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Developing artificial intelligence (AI) for clinical research requires a comprehensive data foundation that supports model training and rigorous evaluation. Here, we introduce TrialPanorama, a large-scale structured resource that aggregates 1.6M clinical trial records from fifteen global registries and links them with biomedical ontologies and associated literature. To demonstrate its utility, we build a pipeline that constructs 152K training and testing samples for eight key clinical research tasks. Three tasks support systematic review workflows, including study search, study screening, and evidence summarization. Five tasks focus on trial design and optimization, including arm design, eligibility criteria design, endpoint selection, sample size estimation, and trial completion assessment and rationalization. Benchmarking cutting-edge large language models (LLMs) reveals that generic LLMs have limited capability in clinical reasoning. In contrast, an 8B LLM we developed on TrialPanorama using supervised finetuning and reinforcement learning wins over the 70B generic counterparts in all eight tasks, with a relative improvement of 73.7%, 67.6%, 38.4%, 37.8%, 26.5%, 20.7%, 20.0%, 18.1%, and 5.2%, respectively. We envision that TrialPanorama provides a solid foundation for future scaling of AI for clinical research.

